Patents over Patients: How Pharmaceutical Companies use the Patent System to Keep Drug Costs High
Richmond Journal of Law and Technology
NOVEMBER 27, 2023
17] An example of this is seen in a 2014 deal struck by Gilead Sciences, the leading marketer of antiretrovirals used to treat HIV/AIDS. [18] 25] However, due to a 2013 Supreme Court decision in Federal Trade Commission v. 1] One in four Americans report that they simply cannot afford to take their medication as prescribed. [2]
Let's personalize your content